SEC Form 4 · accession 0001209191-16-104133
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Lortie
Officer — President Branded Pharma
Period of report
Feb 26, 2016
Accepted (ET)
Mar 1, 2016 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Feb 26, 2016 | F | 130 | $53.80 | D | 18,720 | D | |
| Ordinary SharesF4,F2,F5 | Feb 27, 2016 | F | 200 | $53.80 | D | 19,169 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of Mr. Lortie's February 26, 2014 grant of restricted stock units (RSUs) vested on February 26, 2016.
- F2These shares represent stock withheld by Endo International plc to satisfy Mr. Lortie's tax withholding obligations on shares acquired upon vesting of RSUs.
- F3$53.80 represents the vesting price, which is the average of the high and low share price on February 26, 2016.
- F4Twenty-five percent (25%) of Mr. Lortie's February 27, 2013 grant of RSUs vested on February 27, 2016.
- F5$53.80 represents the vesting price, which is the average of the high and low share price on February 26, 2016. As February 27, 2016 was a Saturday, the average of the high and low price of Endo International plc stock traded on the prior trading day was utilized.